LILRA1 and acute myeloid leukemia: Among them were immune‐inhibitory leukocyte immunoglobulin‐like receptors: LILRB1, LILRB2, LILRB3, LILRA1, LILRA4;43CX3CR1, and CD1C, commonly expressed in myeloid dendritic cells (mDCs), which modulate T‐cell functions with either stimulatory or suppressive effects;44, 45SIGLEC7, an inhibitory receptor expressed on NK cells that could indicate NK cell dysfunction in AML.46, 47